Literature DB >> 20604988

Lentivirally mediated GSK-3β silencing in the hippocampal dentate gyrus induces antidepressant-like effects in stressed mice.

Naoto Omata1, Chi-Tso Chiu, Pablo R Moya, Yan Leng, Zhifei Wang, Joshua G Hunsberger, Peter Leeds, De-Maw Chuang.   

Abstract

Inhibition of glycogen synthase kinase-3 (GSK-3) by pharmacological tools can produce antidepressant-like effects in rodents. However, the GSK-3 isoform(s) and brain region(s) involved in regulating these behavioural effects remain elusive. We studied the effects of bilateral intra-hippocampal injections of lentivirus-expressing short-hairpin (sh)RNA targeting GSK-3β on behavioural performance in mice subjected to chronic stress. Pre-injection of lentivirus-expressing GSK-3β shRNA into the hippocampal dentate gyrus significantly decreased immobility time in both forced swim and tail suspension tests, while the locomotor activity of these mice was unchanged. These results suggest that lentiviral GSK-3β shRNA injection induces antidepressant-like effects in chronically stressed mice. Under these conditions, the expression levels of GSK-3β were persistently and markedly reduced in the hippocampus following GSK-3β shRNA injection. To our knowledge, this is the first demonstration that a single injection of lentivirus-expressing GSK-3β shRNA in the hippocampal dentate gyrus of chronically stressed mice has antidepressant-like effects elicited by gene silencing.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20604988      PMCID: PMC3125712          DOI: 10.1017/S1461145710000726

Source DB:  PubMed          Journal:  Int J Neuropsychopharmacol        ISSN: 1461-1457            Impact factor:   5.176


  26 in total

1.  How valuable are animal models in defining antidepressant activity?

Authors:  M Bourin; A. J Fiocco; F Clenet
Journal:  Hum Psychopharmacol       Date:  2001-01       Impact factor: 1.672

2.  Differential roles of glycogen synthase kinase-3 isoforms in the regulation of transcriptional activation.

Authors:  Min-Huei Liang; De-Maw Chuang
Journal:  J Biol Chem       Date:  2006-08-15       Impact factor: 5.157

3.  Deficiency in the inhibitory serine-phosphorylation of glycogen synthase kinase-3 increases sensitivity to mood disturbances.

Authors:  Abigail Polter; Eléonore Beurel; Sufen Yang; Rakesha Garner; Ling Song; Courtney A Miller; J David Sweatt; Lori McMahon; Alfred A Bartolucci; Xiaohua Li; Richard S Jope
Journal:  Neuropsychopharmacology       Date:  2010-03-31       Impact factor: 7.853

4.  Selective loss of brain-derived neurotrophic factor in the dentate gyrus attenuates antidepressant efficacy.

Authors:  Megumi Adachi; Michel Barrot; Anita E Autry; David Theobald; Lisa M Monteggia
Journal:  Biol Psychiatry       Date:  2007-11-05       Impact factor: 13.382

5.  Increased neurogenesis and the ectopic granule cells after intrahippocampal BDNF infusion in adult rats.

Authors:  Helen Scharfman; Jeffrey Goodman; Adam Macleod; Sudar Phani; Cara Antonelli; Susan Croll
Journal:  Exp Neurol       Date:  2005-04       Impact factor: 5.330

6.  Influence of genes and environment on brain volumes in twin pairs concordant and discordant for bipolar disorder.

Authors:  Astrid C van der Schot; Ronald Vonk; Rachel G H Brans; Neeltje E M van Haren; P Cédric M P Koolschijn; Valerie Nuboer; Hugo G Schnack; G Caroline M van Baal; Dorret I Boomsma; Willem A Nolen; Hilleke E Hulshoff Pol; René S Kahn
Journal:  Arch Gen Psychiatry       Date:  2009-02

7.  Lithium blocks stress-induced changes in depressive-like behavior and hippocampal cell fate: the role of glycogen-synthase-kinase-3beta.

Authors:  R Silva; A R Mesquita; J Bessa; J C Sousa; I Sotiropoulos; P Leão; O F X Almeida; N Sousa
Journal:  Neuroscience       Date:  2007-12-23       Impact factor: 3.590

8.  TrkB regulates hippocampal neurogenesis and governs sensitivity to antidepressive treatment.

Authors:  Yun Li; Bryan W Luikart; Shari Birnbaum; Jian Chen; Chang-Hyuk Kwon; Steven G Kernie; Rhonda Bassel-Duby; Luis F Parada
Journal:  Neuron       Date:  2008-08-14       Impact factor: 17.173

9.  Rapid antidepressive-like activity of specific glycogen synthase kinase-3 inhibitor and its effect on beta-catenin in mouse hippocampus.

Authors:  Oksana Kaidanovich-Beilin; Anat Milman; Abraham Weizman; Chaim G Pick; Hagit Eldar-Finkelman
Journal:  Biol Psychiatry       Date:  2004-04-15       Impact factor: 13.382

10.  The Wnt pool of glycogen synthase kinase 3beta is critical for trophic-deprivation-induced neuronal death.

Authors:  Vesa Hongisto; Jenni C Vainio; Róisín Thompson; Michael J Courtney; Eleanor T Coffey
Journal:  Mol Cell Biol       Date:  2008-01-14       Impact factor: 4.272

View more
  29 in total

Review 1.  Review of pharmacological treatment in mood disorders and future directions for drug development.

Authors:  Xiaohua Li; Mark A Frye; Richard C Shelton
Journal:  Neuropsychopharmacology       Date:  2011-09-07       Impact factor: 7.853

2.  FKBP51 inhibits GSK3β and augments the effects of distinct psychotropic medications.

Authors:  N C Gassen; J Hartmann; A S Zannas; A Kretzschmar; J Zschocke; G Maccarrone; K Hafner; A Zellner; L K Kollmannsberger; K V Wagner; D Mehta; S Kloiber; C W Turck; S Lucae; G P Chrousos; F Holsboer; E B Binder; M Ising; M V Schmidt; T Rein
Journal:  Mol Psychiatry       Date:  2015-04-07       Impact factor: 15.992

3.  PPARgamma agonists rescue increased phosphorylation of FGF14 at S226 in the Tg2576 mouse model of Alzheimer's disease.

Authors:  Wei-Chun J Hsu; Norelle C Wildburger; Sigmund J Haidacher; Miroslav N Nenov; Oluwarotimi Folorunso; Aditya K Singh; Brent C Chesson; Whitney F Franklin; Ibdanelo Cortez; Rovshan G Sadygov; Kelly T Dineley; Jay S Rudra; Giulio Taglialatela; Cheryl F Lichti; Larry Denner; Fernanda Laezza
Journal:  Exp Neurol       Date:  2017-05-15       Impact factor: 5.330

Review 4.  Neuroprotective action of lithium in disorders of the central nervous system.

Authors:  Chi-Tso Chiu; De-Maw Chuang
Journal:  Zhong Nan Da Xue Xue Bao Yi Xue Ban       Date:  2011-06

Review 5.  Wnt and lithium: a common destiny in the therapy of nervous system pathologies?

Authors:  Delphine Meffre; Julien Grenier; Sophie Bernard; Françoise Courtin; Todor Dudev; Ghjuvan'Ghjacumu Shackleford; Mehrnaz Jafarian-Tehrani; Charbel Massaad
Journal:  Cell Mol Life Sci       Date:  2013-06-09       Impact factor: 9.261

6.  Combined treatment with the mood stabilizers lithium and valproate produces multiple beneficial effects in transgenic mouse models of Huntington's disease.

Authors:  Chi-Tso Chiu; Guangping Liu; Peter Leeds; De-Maw Chuang
Journal:  Neuropsychopharmacology       Date:  2011-07-27       Impact factor: 7.853

Review 7.  Molecular actions and therapeutic potential of lithium in preclinical and clinical studies of CNS disorders.

Authors:  Chi-Tso Chiu; De-Maw Chuang
Journal:  Pharmacol Ther       Date:  2010-08-10       Impact factor: 12.310

Review 8.  Regulation of inflammation and T cells by glycogen synthase kinase-3: links to mood disorders.

Authors:  Eleonore Beurel
Journal:  Neuroimmunomodulation       Date:  2014-02-14       Impact factor: 2.492

9.  GSK3β isoform-selective regulation of depression, memory and hippocampal cell proliferation.

Authors:  M Pardo; E Abrial; R S Jope; E Beurel
Journal:  Genes Brain Behav       Date:  2016-02-12       Impact factor: 3.449

10.  Hippocampal GSK3β as a Molecular Link Between Obesity and Depression.

Authors:  Ioannis K Papazoglou; Arnaud Jean; Arieh Gertler; Mohammed Taouis; Claire-Marie Vacher
Journal:  Mol Neurobiol       Date:  2014-08-29       Impact factor: 5.590

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.